Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

New liver cell discovery may enable hepatic regeneration

Aug. 9, 2019

Immuron reports data from TREAT-003 study of IMM-124-E in severe alcoholic hepatitis

Aug. 9, 2019

89bio initiates phase Ib/IIa study of BIO89-100 for the treatment of NASH

Aug. 9, 2019

Noggin and asporin are diagnostic markers of NAFLD

Aug. 7, 2019

Galectin Therapeutics submits phase III protocol for NASH-RX trial to the FDA

Aug. 6, 2019

Poxel initiates PK/PD trial as part of its phase IIa clinical program for PXL-770

Aug. 5, 2019

Phase I study of PN-943 demonstrates sustained dose-related target engagement activity

Aug. 2, 2019

Developmental biliary agenesis in ALGS is reversible via restoration of Jagged/Notch

Aug. 1, 2019

EDP-305 demonstrates preferential penetration of NASH organs

July 31, 2019

FDA clears Hepion's IND application to study CRV-431 for NASH

July 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...